載入...
CAUTION ADVISED USING COMBINATION KETOCONAZOLE AND PD-1 INHIBITORS
OBJECTIVE: Immune checkpoint inhibitors are approved to treat multiple cancers. We report life-threatening hepatic failure in 2 consecutive patients with Cushing syndrome that were treated with ketoconazole (KTZ) in combination with 2 different programmed cell death protein 1 (PD-1) inhibitors, Nivo...
Na minha lista:
| 發表在: | AACE Clin Case Rep |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Association of Clinical Endocrinologists
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7511096/ https://ncbi.nlm.nih.gov/pubmed/32984529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2020-0100 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|